Jacob Sonenshine is a Reporter at Barron's. He covers a range of topics in finance, including stocks and bonds, investment strategies, and energy trading, with a keen interest in personal finance and alternative investments. Jacob's work has been featured in Financial News, Yahoo Finance, MarketWatch, and several other reputable outlets.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Jacob Sonenshine's coverage primarily focuses on investment analysis, with an emphasis on the stock market and specific sectors such as bank stocks. He frequently cites data in his articles, indicating a preference for fact-based insights.
Given his focus, Jacob would likely be interested in receiving input from financial analysts or experts who can provide detailed and data-driven perspectives on the stock market trends, particularly within small-cap stocks, S&P 500 movements, and bank stocks' performance.
While he doesn't have a specified geographic focus, Jacob predominantly covers the United States’ financial landscape. Therefore, pitches should align with developments relevant to this region unless they have broader global implications.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Neurocrine Biosciences has retreated from its all-time high, creating a buying opportunity for the next phase of growth.
By: Jacob Sonenshine
This is the moment to reallocate some money to non-technology stocks.
By: Jacob Sonenshine
Technology stocks are approaching their peak as a portion of the S&P 500, which could portend some rough months ahead.
By: Jacob Sonenshine
Higher-quality cyclicals could perform solidly even if the economy goes into recession.
By: Jacob Sonenshine
Stocks that are sensitive to the economy, or “cyclical,” are beaten down—and look attractive. Selectivity is key.
Equinox Gold has quietly transformed its operations. The stock is a buy.
Out of all the ways to benefit from a potential gold rally, buying stock in the $12 billion miner Equinox Gold is among the best.
The company has quietly transformed its operations. The stock is a buy.
Big tech's earnings are usually a tell for chip demand, but this week they came with mixed signals. Now, the market will look to a few events in the coming months to reignite chip stocks.
By: Jacob Sonenshine
Several catalysts are on the calendar for semiconductor companies.
